Testing effectiveness (Phase 2)Study completedNCT01959633
What this trial is testing
Vemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
Who this might be right for
Melanoma
Fondazione Melanoma Onlus 11